Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | 0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 0.01 |
| enterprise value multiple | 0.19 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 48.15% |
| operating profit margin | -15614.81% |
| pretax profit margin | -16213.58% |
| net profit margin | -16213.58% |
| return on assets | -96.81% |
| return on equity | 882.0% |
| return on capital employed | -1619.46% |
liquidity ratio | |
|---|---|
| current ratio | 1.03 |
| quick ratio | 1.03 |
| cash ratio | 0.61 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 7,443.39 |
| cash conversion cycle | -7,443.39 |
| receivables turnover | 0.00 |
| payables turnover | 0.05 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.75 |
| debt equity ratio | 24.48 |
| long term debt to capitalization | 0.18 |
| total debt to capitalization | 0.96 |
| interest coverage | -11.21 |
| cash flow to debt ratio | -1.02 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.06 |
| cash per share | 6.22 |
| operating cash flow per share | -5.05 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.02 |
| short term coverage ratios | -1.03 |
| capital expenditure coverage ratio | -367.84 |
Frequently Asked Questions
eFFECTOR Therapeutics, Inc. (EFTR) published its most recent earnings results on 09-05-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR)'s trailing twelve months ROE is 882.0%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. eFFECTOR Therapeutics, Inc. (EFTR) currently has a ROA of -96.81%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
EFTR reported a profit margin of -16213.58% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.03 in the most recent quarter. The quick ratio stood at 1.03, with a Debt/Eq ratio of 24.48.